Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-04-21 Sale | 2022-04-25 12:12 pm | Pyxis Oncology Inc. | PYXS | Chin Mark Former Director | 1,745,761 | $3.05 | $5,324,571 | 0 (Indirect) | View |
| 2021-12-08 Purchase | 2021-12-09 4:18 pm | Pyxis Oncology Inc. | PYXS | Cline Darren S Director | 10,000 | $9.3885 | $93,885 | 10,000 (Direct) | View |
| 2021-11-18 Purchase | 2021-11-19 1:21 pm | Pyxis Oncology Inc. | PYXS | Civik Thomas Director | 15,700 | $12.74 | $200,018 | 15,700 (Indirect) | View |
| 2021-10-13 Purchase | 2021-10-15 5:37 pm | Pyxis Oncology Inc. | PYXS | Chin Mark Director | 312,500 | $16 | $5,000,000 | 1,745,761 (Indirect) | View |
| 2021-10-13 Purchase | 2021-10-15 4:12 pm | Pyxis Oncology Inc. | PYXS | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 450,000 | $16 | $7,200,000 | 1,118,854 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-10-06 Ownership | 2022-10-13 08:34 am | N/A N/A | Pyxis Oncology Inc. | PYXS | PFIZER INC Pfizer Ventures (US) LLC 10% Owner | 0 | $0 | 5,221,176 (Direct) | View |
| 2022-08-11 Option Award | 2022-08-15 5:44 pm | N/A 2032-08-11 | Pyxis Oncology Inc. | PYXS | HUMPHREY RACHEL Director | 236,220 | $0 | 236,220 (Direct) | View |
| 2022-08-03 Ownership | 2022-08-09 4:34 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Wadhane Jitendra CAO | 0 | $0 | 200,905 (Direct) | View |
| 2022-04-25 Ownership | 2022-04-26 1:40 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | BARCLAYS PLC 10% Owner | 0 | $0 | 3,477,975 (Indirect) | View |
| 2022-04-14 Option Award | 2022-04-15 8:00 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Yanchik Connealy Pamela CFO | 93,493 | $0 | 341,017 (Direct) | View |
| 2022-04-14 Option Award | 2022-04-15 7:58 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Feingold Jay Chief Medical Officer | 115,931 | $0 | 466,611 (Direct) | View |
| 2022-04-14 Option Award | 2022-04-15 7:56 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Sullivan Lara CEO | 315,273 | $0 | 1,356,636 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 4:16 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | FLAVIN JOHN L Director | 66,831 | $0 | 238,441 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 4:16 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Feingold Jay Chief Medical Officer | 306,930 | $0 | 350,680 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 4:15 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Sullivan Lara CEO | 742,574 | $0 | 1,041,363 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 4:15 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Civik Thomas Director | 66,831 | $0 | 82,531 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 4:15 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Cline Darren S Director | 66,831 | $0 | 76,831 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 4:15 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Chin Mark Director | 66,831 | $0 | 1,812,592 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 4:15 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Yanchik Connealy Pamela CFO | 247,524 | $0 | 247,524 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 4:15 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Lewis-Hall Freda C Director | 66,831 | $0 | 66,831 (Direct) | View |
| 2021-12-06 Option Award | 2021-12-07 3:36 pm | N/A 2031-12-06 | Pyxis Oncology Inc. | PYXS | Yanchik Connealy Pamela CFO | 52,944 | $0 | 52,944 (Direct) | View |
| 2021-10-13 Conversion | 2021-10-15 5:37 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Chin Mark Director | 10,547,370 | $0 | 1,745,761 (Indirect) | View |
| 2021-10-13 Conversion | 2021-10-15 5:35 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | FLAVIN JOHN L Director | 17,578 | $0 | 171,610 (Direct) | View |
| 2021-10-13 Conversion | 2021-10-15 5:05 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Bayer World Investments B.V. BAYER AKTIENGESELLSCHAFT Former 10% Owner | 20,180,872 | $0 | 2,742,338 (Direct) | View |
| 2021-10-13 Conversion | 2021-10-15 4:12 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 668,854 | $0 | 1,118,854 (Indirect) | View |
| 2021-10-07 Option Award | 2021-10-12 7:47 pm | N/A 2031-10-07 | Pyxis Oncology Inc. | PYXS | Civik Thomas Director | 42,191 | $0 | 42,191 (Direct) | View |
| 2021-10-07 Option Award | 2021-10-12 7:47 pm | N/A 2031-10-07 | Pyxis Oncology Inc. | PYXS | FLAVIN JOHN L Director | 42,191 | $0 | 42,191 (Direct) | View |
| 2021-10-07 Option Award | 2021-10-12 7:47 pm | N/A 2031-10-07 | Pyxis Oncology Inc. | PYXS | Cline Darren S Director | 42,191 | $0 | 42,191 (Direct) | View |
| 2021-10-07 Option Award | 2021-10-12 7:47 pm | N/A 2031-10-07 | Pyxis Oncology Inc. | PYXS | Feingold Jay Chief Medical Officer | 480,679 | $0 | 480,679 (Direct) | View |
| 2021-10-07 Option Award | 2021-10-12 7:47 pm | N/A 2031-10-07 | Pyxis Oncology Inc. | PYXS | Chin Mark Director | 42,191 | $0 | 42,191 (Direct) | View |
| 2021-10-07 Option Award | 2021-10-12 7:47 pm | N/A 2031-10-07 | Pyxis Oncology Inc. | PYXS | Lewis-Hall Freda C Director | 42,191 | $0 | 42,191 (Direct) | View |
| 2021-10-07 Option Award | 2021-10-12 7:47 pm | N/A 2031-10-07 | Pyxis Oncology Inc. | PYXS | Sullivan Lara CEO | 962,289 | $0 | 962,289 (Direct) | View |
| 2021-10-07 Option Award | 2021-10-12 7:47 pm | N/A 2031-10-07 | Pyxis Oncology Inc. | PYXS | Herbst Ronald Chief Scientific Officer | 28,252 | $0 | 28,252 (Direct) | View |
| 2021-10-07 Option Award | 2021-10-12 7:47 pm | N/A 2031-10-07 | Pyxis Oncology Inc. | PYXS | Shah Ritu Chief Operating Officer | 31,344 | $0 | 31,344 (Direct) | View |
| 2021-10-07 Ownership | 2021-10-07 9:28 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Sullivan Lara CEO | 0 | $0 | 1,351,075 (Direct) | View |
| 2021-10-07 Ownership | 2021-10-07 9:25 pm | N/A 2031-03-30 | Pyxis Oncology Inc. | PYXS | Shah Ritu Chief Operating Officer | 0 | $0 | 265,024 (Direct) | View |
| 2021-10-07 Ownership | 2021-10-07 9:21 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | FLAVIN JOHN L Director | 0 | $0 | 187,335 (Direct) | View |
| 2021-10-07 Ownership | 2021-10-07 9:18 pm | N/A N/A | Pyxis Oncology Inc. | PYXS | Herbst Ronald Chief Scientific Officer | 0 | $0 | 397,864 (Direct) | View |
| 2021-10-07 Ownership | 2021-10-07 9:18 pm | N/A N/A | Pyxis Oncology Inc. | PYXO | Bayer World Investments B.V. BAYER AKTIENGESELLSCHAFT 10% Owner | 0 | $0 | 2,742,338 (Direct) | View |
| 2021-10-07 Ownership | 2021-10-07 9:15 pm | N/A 2031-09-12 | Pyxis Oncology Inc. | PYXS | Feingold Jay Chief Medical Officer | 0 | $0 | 174,774 (Direct) | View |